Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Gastroenterology. 2014 Jul 16;147(4):870–881.e8. doi: 10.1053/j.gastro.2014.07.005

Figure 5. Higher polyfunctionality of HCV-specific CD8 T cells targeting minimal epitopes in SR/SR patients in comparison to SR/CI patients during reinfection.

Figure 5

PBMCs from the indicated time points were stimulated overnight with the minimum cognate peptide and ICS/CD107a staining was performed. Representative results from two SR/SR patients (A B) and two SR/CI patients (C and D), gated on viable CD3+CD8+ T lymphocytes. Peptides used are: 1073 = A2 restricted NS3-1073 and 2594 = A2 restricted NS5B-2594.